Who is sponsoring NCT05608356?

NCT05608356 is sponsored by Cairo University.

What drugs are being tested in NCT05608356?

Interventions in NCT05608356: injectable platelet rich fibrin(i-prf), Sham Injection.

What condition does NCT05608356 study?

NCT05608356 studies Platelet-rich Fibrin.

Is NCT05608356 still recruiting?

NCT05608356 is currently status unknown. Last updated 8 November 2022.

Last reviewed 2022-11-08 · How we verify

NCT05608356

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Injectable Platelet-rich Fibrin on the En Masse Retraction of Maxillary Anterior Teeth

Status unknown NA Last updated 8 November 2022

What this trial tests

NA trial testing injectable platelet rich fibrin(i-prf) in Platelet-rich Fibrin in 26 participants. Status unknown.

Timeline

1 December 2022

Primary endpoint
30 November 2023

30 November 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	26
Start date	1 December 2022
Primary completion	30 November 2023
Estimated completion	30 November 2023
Sites	1 location across Egypt

Drugs / interventions tested

injectable platelet rich fibrin(i-prf)
Sham Injection — full drug profile →

Conditions studied

Platelet-rich Fibrin — all drugs for Platelet-rich Fibrin →

Sponsor

Cairo University

Who can join

Adults 16 to 30, any sex, with Platelet-rich Fibrin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of local injection of injectable platelet rich fibrin (i-PRF) on the rate of orthodontic en masse retraction of anterior teeth clinically and to report any associated pain as well.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Platelet-rich Fibrin

Currently open trials in the same condition.

NCT06440655 — The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05608356 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 8 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05608356.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing